Literature DB >> 29981865

CasPER, a method for directed evolution in genomic contexts using mutagenesis and CRISPR/Cas9.

Tadas Jakočiūnas1, Lasse E Pedersen1, Alicia V Lis1, Michael K Jensen2, Jay D Keasling3.   

Abstract

Here we describe a method for robust directed evolution using mutagenesis of large sequence spaces in their genomic contexts. The method employs error-prone PCR and Cas9-mediated genome integration of mutant libraries of large-sized donor variants into single or multiple genomic sites with efficiencies reaching 98-99%. From sequencing of genome integrants, we determined that the mutation frequency along the donor fragments is maintained evenly and successfully integrated into the genomic target loci, indicating that there is no bias of mutational load towards the proximity of the double strand break. To validate the applicability of the method for directed evolution of metabolic gene products we engineered two essential enzymes in the mevalonate pathway of Saccharomyces cerevisiae with selected variants supporting up to 11-fold higher production of isoprenoids. Taken together, our method extends on existing CRISPR technologies by facilitating efficient mutagenesis of hundreds of nucleotides in cognate genomic contexts.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29981865     DOI: 10.1016/j.ymben.2018.07.001

Source DB:  PubMed          Journal:  Metab Eng        ISSN: 1096-7176            Impact factor:   9.783


  19 in total

1.  Tools and systems for evolutionary engineering of biomolecules and microorganisms.

Authors:  Sungho Jang; Minsun Kim; Jaeseong Hwang; Gyoo Yeol Jung
Journal:  J Ind Microbiol Biotechnol       Date:  2019-05-27       Impact factor: 3.346

2.  Efficient, continuous mutagenesis in human cells using a pseudo-random DNA editor.

Authors:  Haiqi Chen; Sophia Liu; Samuel Padula; Daniel Lesman; Kettner Griswold; Allen Lin; Tongtong Zhao; Jamie L Marshall; Fei Chen
Journal:  Nat Biotechnol       Date:  2019-12-16       Impact factor: 54.908

3.  Scalable, Continuous Evolution of Genes at Mutation Rates above Genomic Error Thresholds.

Authors:  Arjun Ravikumar; Garri A Arzumanyan; Muaeen K A Obadi; Alex A Javanpour; Chang C Liu
Journal:  Cell       Date:  2018-11-08       Impact factor: 41.582

4.  CRISPR-based oligo recombineering prioritizes apicomplexan cysteines for drug discovery.

Authors:  H J Benns; M Storch; J A Falco; F R Fisher; F Tamaki; E Alves; C J Wincott; R Milne; N Wiedemar; G Craven; B Baragaña; S Wyllie; J Baum; G S Baldwin; E Weerapana; E W Tate; M A Child
Journal:  Nat Microbiol       Date:  2022-10-20       Impact factor: 30.964

5.  Saccharomyces cerevisiae as a Heterologous Host for Natural Products.

Authors:  Maximilian Otto; Dany Liu; Verena Siewers
Journal:  Methods Mol Biol       Date:  2022

Review 6.  Genome editing systems across yeast species.

Authors:  Zhiliang Yang; Mark Blenner
Journal:  Curr Opin Biotechnol       Date:  2020-10-01       Impact factor: 9.740

Review 7.  Synthetic evolution.

Authors:  Anna J Simon; Simon d'Oelsnitz; Andrew D Ellington
Journal:  Nat Biotechnol       Date:  2019-06-17       Impact factor: 54.908

8.  CRISPR/Cas9-facilitated engineering with growth-coupled and sensor-guided in vivo screening of enzyme variants for a more efficient chorismate pathway in E. coli.

Authors:  Minliang Chen; Lin Chen; An-Ping Zeng
Journal:  Metab Eng Commun       Date:  2019-05-06

Review 9.  Genome editor-directed in vivo library diversification.

Authors:  Cristina Cheng; Mi Zhou; Qiwen Su; Alexandra Steigmeyer; Jia Niu
Journal:  Cell Chem Biol       Date:  2021-06-08       Impact factor: 9.039

Review 10.  Blossom of CRISPR technologies and applications in disease treatment.

Authors:  Huayi Liu; Lian Wang; Yunzi Luo
Journal:  Synth Syst Biotechnol       Date:  2018-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.